Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Fujita Innovation Capital

Profile and portfolio

Parent Fujita GakuenHQ Toyoake, JapanFounded 2019

Fujita Innovation Capital is the corporate venture arm of Fujita Gakuen, a healthcare company. It was founded in 2019 and is based in Toyoake, Japan. It invests at the Series B stage. Sectors it names: biotech and life sciences, healthcare and digital health.

Every figure links to its source

Snapshot

Investment stage: Series B to Series B
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries B to Series B
SectorsBiotech and life sciences, Healthcare and digital health
GeographyAsia
OfficesToyoake, Japan, Tokyo, Japan

Sources: S3 PR TIMES via Jiji Medical: CardioIntelligence Series B first close with Fujita Innovation Capital / Tokai Tokyo Investment fund (2025-11-20); S1 Fujita Innovation Capital home (Japanese).

Graphic 1 of 1

Investment stage: Series B to Series B

Sources: S3 PR TIMES via Jiji Medical: CardioIntelligence Series B first close with Fujita Innovation Capital / Tokai Tokyo Investment fund (2025-11-20); S1 Fujita Innovation Capital home (Japanese).

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Toyoake, Japan
Offices

Investment regionsS3S1

LeadersS2S4

Fujita Innovation Capital on LinkedIn

Key facts

FactValueStatusSource
Parent companyFujita GakuenSingle sourceS1
Parent industryHealthcare and life sciencesSingle sourceS1
Founded2019Single sourceS1
HeadquartersToyoake, JapanSingle sourceS2
StatusActiveSingle sourceS1
StagesSeries B (inferred from announced rounds)EstimateS3

Fund vehicles

VehicleSizeYearSource
Fujita TT Impact Fund No. 1Not published2022S1

Portfolio

The firm's portfolio page lists 5 companies.S1

Shared portfolio with other corporate VCs

1 companies on the Fujita Innovation Capital portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
NCB Venture Capital1サーブ・バイオファーマ

Companies backed by the most corporate VCs

Every company on the Fujita Innovation Capital list

5 companies, as listed on the firm's own website.S1 Read the firm's list.

  • ウェルモ
  • カルディオインテリジェンス
  • サーブ・バイオファーマ
  • メタジェンセラピューティクス
  • ユナイテッド・イミュニティ

Official pages

Read the firm's own pages for current information.

Sources

  1. S1Fujita Innovation Capital home (Japanese)Firm
  2. S2Fujita Innovation Capital company overview (Japanese)Firm
  3. S3PR TIMES via Jiji Medical: CardioIntelligence Series B first close with Fujita Innovation Capital / Tokai Tokyo Investment fund (2025-11-20)Portfolio company
  4. S4Tokai Tokyo Investment release: United Immunity investment via Fujita TT Impact Fund No.1 (2026-03-30)Third-party report

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Fujita Innovation Capital or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.